DMEMEDS shared post via NYT: DealBook: Dimon's Cancer and the Fine Line in Revealing Illness of a C.E.O.

Corporate leaders have wrestled with how -- or whether -- to go public about health problems. How much to disclose, and when, involves delicate corporate and personal decisions for which there are few hard rules. [Category: Investment Banking, Top Headline 1, Corporate Governance] http://rss.nytimes.com/c/34625/f/640346/s/3c1ef7b7/sc/24/l/0Ldealbook0Bnytimes0N0C20A140C0A70C0A20Cjamie0Edimons0Ecancer0Erevelation0Eraises0Equestions0Eabout0Edisclosing0Ethe0Ec0Ee0Eo0Es0Eillness0C0Dpartner0Frss0Gemc0Frss/story01.htm

Read More